Specific high-performance liquid chromatography assay for determination of rifabutin plasma concentration following Extrelut column extraction

被引:8
作者
Gatti, G [1 ]
De Pascalis, CR [1 ]
Miletich, F [1 ]
Casazza, R [1 ]
Bassetti, D [1 ]
机构
[1] Univ Genoa, Osped San Martino, Dept Infect Dis 1, I-16132 Genoa, Italy
来源
JOURNAL OF CHROMATOGRAPHY B | 1999年 / 728卷 / 02期
关键词
rifabutin;
D O I
10.1016/S0378-4347(99)00106-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A specific, precise and accurate assay for determination of rifabutin in human plasma using Extrelut column extraction was developed and validated. Rifabutin concentrations were calculated with a standard curve ranging from 5 to 800 ng ml(-1), using a split-curve approach. Chromatographic peaks were separated by means of a 5 mu m Symmetry Shield RP8 using a KH2PO4 (0.05 M) buffer-acetonitrile mobile phase. Detection wavelength was set at 275 nm. Chromatography was carried out at room temperature (20-25 degrees C). The limit of quantification was 5 ng ml(-1). The recovery was over 71%. The intra-day precision of the assay was 5, 7, and 1% while the inter-day precision was 11.2, 8.1, and 5.8% at concentrations of 30, 150 and 500 ng ml(-1), respectively. The accuracy ranged from 99 to 108%. Forty of the drugs most commonly administered to HIV-positive patients were found not to interfere with the assay. The assay has been used in a comparative study of rifabutin pharmacokinetics in HIV-positive patients with or without wasting syndrome. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 9 条
[1]   Determination of rifabutin by high-performance liquid chromatography using on-line concentration and column switching [J].
Bartels, H ;
Bartels, R .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 686 (02) :235-240
[2]  
GATTI G, UNPUB BR J CLIN PHAR
[3]  
Lau YY, 1996, J CHROMATOGR B, V676, P125
[4]   A SENSITIVE METHOD FOR QUANTITATION OF RIFABUTIN AND ITS DESACETYL METABOLITE IN HUMAN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY (HPLC) [J].
LEWIS, RC ;
HATFIELD, NZ ;
NARANG, PK .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1434-1440
[5]  
McCrea J., 1997, Clinical Pharmacology and Therapeutics, V61, P152
[6]   2 CONTROLLED TRIALS OF RIFABUTIN PROPHYLAXIS AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN AIDS [J].
NIGHTINGALE, SD ;
CAMERON, DW ;
GORDIN, FM ;
SULLAM, PM ;
COHN, DL ;
CHAISSON, RE ;
ERON, LJ ;
SPARTI, PD ;
BIHARI, B ;
KAUFMAN, DL ;
STERN, JJ ;
PEARCE, DD ;
WEINBERG, WG ;
LAMARCA, A ;
SIEGAL, FP .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (12) :828-833
[7]  
*ROCH LAB, SAQ MES PROD INF
[8]   A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in aids: Rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin [J].
Shafran, SD ;
Singer, J ;
Zarowny, DP ;
Phillips, P ;
Salit, I ;
Walmsley, SL ;
Fong, IW ;
Gill, MJ ;
Rachlis, AR ;
Lalonde, RG ;
Fanning, MM ;
Tsoukas, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (06) :377-383
[9]  
1996, MORBID MORTAL WEEKLY, V45, P921